Biofreedom

DEVICE3 trials

Sponsors

Odense University Hospital, A.O.U. Città della Salute e della Scienza

Conditions

Acute Myocardial InfarctionCoronary DiseaseDrug Eluting StentIschaemic Heart DiseaseSTEMI

Unknown Phase

BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX

CompletedNCT02623140

Odense University HospitalIschaemic Heart Disease

Start: 2015-12-01End: 2023-10-01Updated: 2026-10-22

The SORT OUT IX STEMI OCT Trial

CompletedNCT02915107

Odense University HospitalAcute Myocardial Infarction

Start: 2016-09-01End: 2023-09-01Target: 80Updated: 2026-10-22

Outcome of CHAllenging lesioNs and Patients Treated With Polymer Free Drug-CoatEd Stent

CompletedNCT03622203

A.O.U. Città della Salute e della ScienzaCoronary Disease, Drug Eluting Stent, STEMI

Start: 2016-01-01End: 2018-05-01Updated: 2018-08-09

Related Papers

Randomized Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent With the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated With Percutaneous Coronary Intervention

Circulation2020-05-2170 citations

Real‐world reasons and outcomes for 1‐month versus longer dual antiplatelet therapy strategies with a polymer‐free BIOLIMUS A9‐coated stent

Catheterization and Cardiovascular Interventions2020-02-032 citations

Dual antiplatelet therapy strategies and clinical outcomes in patients treated with polymer-free biolimus A9-coated stents

EuroIntervention2020-02-016 citations

Safety and efficacy of polymer‐free biolimus‐eluting stents versus ultrathin stents in unprotected left main or coronary bifurcation: A propensity score analysis from the RAIN and CHANCE registries

Catheterization and Cardiovascular Interventions2019-08-053 citations

Comparison of the polymer-free biolimus-coated BioFreedom stent with the thin-strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with percutaneous coronary intervention: Rationale and design of the randomized SORT OUT IX trial.

2019-03-1411 citations

High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial.

2018-12-016 citations